PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Berman Institute of Bioethics and Department of Medicine, Johns Hopkins University, Baltimore, MD, USA. Electronic address: jsugarman@jhu.edu.\', \'Vaccine and Infectious Disease Division, Fred Hutchison Cancer Research Center, Seattle, WA, USA.\', \'HIV Prevention Trials Network Leadership and Operations Center, Washington, DC, USA.\', \'Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.\', \'UCLA Center for Clinical AIDS Research and Education, Los Angeles, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2352-3018(21)00153-310.1016/S2352-3018(21)00153-3
?:doi
?:hasPublicationType
?:journal
  • The lancet. HIV
is ?:pmid of
?:pmid
?:pmid
  • 34454678
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Ethical issues in establishing the efficacy and safety of long-acting injectable pre-exposure prophylaxis for HIV prevention: the HPTN 083 trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all